Indegene - Quaterly Results

30 Jan 2025 Evaluate
The Revenue for the quarter ended  December 2024 of Rs. 2867.00 millions grew by 10.27 % from Rs. 2600.00 millions.Profit after tax for the quarter ended December 2024 reported a huge growth of 68.58% to Rs. 499.00  millions from Rs. 296.00 millions.The company reported a good operating profit of 742.00 millions compared to 490.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 2867.00 2600.00 10.27 8270.00 7730.00 6.99 10456.00 10057.00 3.97
Other Income 223.00 120.00 85.83 584.00 300.00 94.67 503.00 368.00 36.68
PBIDT 742.00 490.00 51.43 1962.00 1480.00 32.57 2183.00 2147.00 1.68
Interest 16.00 17.00 -5.88 47.00 51.00 -7.84 66.00 64.00 3.13
PBDT 726.00 473.00 53.49 1915.00 1429.00 34.01 2117.00 2083.00 1.63
Depreciation 65.00 65.00 0.00 193.00 236.00 -18.22 311.00 317.00 -1.89
PBT 661.00 408.00 62.01 1722.00 1193.00 44.34 1806.00 1766.00 2.27
TAX 162.00 112.00 44.64 449.00 308.00 45.78 427.00 464.00 -7.97
Deferred Tax -7.00 -4.00 75.00 -7.00 -14.00 -50.00 -16.00 -33.00 -51.52
PAT 499.00 296.00 68.58 1273.00 885.00 43.84 1379.00 1302.00 5.91
Equity 478.00 444.00 7.66 479.00 444.00 7.88 444.00 443.00 0.23
PBIDTM(%) 25.88 18.85 37.33 23.72 19.15 23.91 20.88 21.35 -2.20

Indegene Share Price

514.55 11.15 (2.21%)
28-Feb-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1593.90
Dr. Reddys Lab 1117.65
Cipla 1410.95
Lupin 1906.20
Zydus Lifesciences 876.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...